AstraZeneca continues to make the case for its Farxiga diabetes drug, highlighting a cardiology analysis that it hopes will convince more doctors to prescribe it in a highly competitive market.
Farxiga is one of AZ’s most important drugs, and sales increased by 14% to $726 million in the first half of the year, although this was slower than the growth seen in 2018 when sales grew at 30 ...
Use of a sodium-glucose cotransporter 2, or SGLT2, inhibitor combined with calorie restriction resulted in greater rates of type 2 diabetes remission compared with calorie restriction alone, according ...
Earlier this month, a federal judge in Delaware ruled against AstraZeneca’s complaint that sought to halt ongoing negotiations of the price of its diabetes drug, Farxiga (dapagliflozin).
Popular diabetes drugs such as Ozempic and Trulicity are ... The drugs are Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and the insulins Fiasp and NovoLog.